The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| EQUILLIUM INC | COM | 29446K106 | 386 | 47,343 | SH | SOLE | 47,343 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 149,235 | 5,753,096 | SH | SOLE | 5,753,096 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 1,698 | 65,445 | SH | OTR | 1 | 0 | 65,445 | 0 | |
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 34,315 | 3,638,893 | SH | SOLE | 3,638,893 | 0 | 0 | ||
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 2,263 | 240,000 | SH | OTR | 1 | 0 | 240,000 | 0 | |
| ODONATE THERAPEUTICS INC | COM | 676079106 | 197,785 | 14,047,250 | SH | SOLE | 14,047,250 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 720 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 490 | 47,610 | SH | SOLE | 47,610 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 5,035 | 247,400 | SH | SOLE | 247,400 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 43,948 | 2,965,485 | SH | SOLE | 2,965,485 | 0 | 0 | ||